Gemcitabine associated retinopathy and nephropathy
Alan T Sheyman1, Kenneth J Wald, Patricia J Pahk
1*Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York; †Department of Ophthalmology, NYU School of Medicine, New York, New York; and ‡Vitreous Retina Macula Consultants of New York, New York, New York.
Purpose:
To report a case of presumed gemcitabine-induced retinopathy and nephropathy.
Methods:
Case Report. Retrospective chart review.
Results:
A 64-year-old woman with a recent diagnosis of metastatic cholangiocarcinoma presented with progressive visual loss and renal failure shortly after the initiation of a chemotherapy regimen which included gemcitabine. Clinical examination and fluorescein angiography showed findings of severe retinal ischemia.
Conclusion:
Although gemcitabine chemotherapy has been reported to cause a Purtscher-like retinopathy, we propose in our patient a gemcitabine-induced vasculopathy that lead to significant retinal and renal ischemia.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Diabetic Retinopathy
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Diabetic Nephropathy
Cytomegalovirus Disease
